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Abstract
Objective: To evaluate, in vitro, the antimicrobial activity and biofilm formation of three chlorhexidine varnishes 
in four Enterococcus faecalis strains: E. faecalis ATCC 29212, E. faecalis EF-D1 (from failed endodontic treat-
ment), E. faecalis 072 (cheese) and E. faecalis U-1765 (nosocomial infection), and one Enterococcus durans strain 
(failed endodontic treatment). 
Study Design: The direct contact test was used to study the antimicrobial activity. Bacterial suspensions were ex-
posed for one hour to EC40, Cervitec (CE) and Cervitec Plus (CEP) varnishes. “Eradication” was defined as 100% 
bacterial kill. The formation of enterococci biofilms was tested on the surface of the varnishes after 24 hours of 
incubation and expressed as percentage of biofilm reduction. 
Results: EC40 eradicated all strains except E. faecalis ATCC 29212, where 98.78% kill was achieved. CE and CEP 
showed antimicrobial activity against all the strains, but most clearly against E. durans and E. faecalis 072. EC40 
completely inhibited the formation of biofilm of E. faecalis ATCC 29212, E. faecalis 072 and E. durans. CE and 
CEP led to over 92% of biofilm reduction, except in the case of E. faecalis U-1765 on CEP (76.42%). 
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Conclusion: The three varnishes studied were seen to be effective in killing the tested strains of enterococci and in 
inhibiting the formation of biofilm, the best results being observed with EC40.
Key words: Biofilm, chlorhexidine varnish, direct contact test, Enterococcus durans, Enterococcus faecalis, intraca-
nal medication.
Introduction
An important aim of endodontic therapy is the elimina-
tion of microorganisms from root canal systems. This 
may be accomplished using mechanical instrumenta-
tion and chemical irrigation, and intracanal medication 
for persistent infections (1).
Chlorhexidine (CHX) is a cationic molecule with a wide 
antimicrobial spectrum against both Gram positive and 
Gram negative bacteria (2). These would include Entero-
coccus faecalis (3), a microorganism frequently isolated 
from necrotic and failed endodontic treatments (4). Its 
antibacterial activity and substantivity (5) make CHX 
widely used as a root canal irrigant (6,7) and intracanal 
medication (8) and it is known to reduce and/or delay the 
entry of bacteria into the root canal system (9).
Available in different formulations, CHX is commonly 
used in endodontics as a solution or gel (2). CHX has 
recently been incorporated into a variety of sustained-
release systems, including varnishes, in order to pro-
long the period of active-agent delivery and achieve 
maximum antimicrobial effectiveness (10). Some of 
these slow-release systems have proven effective as 
intracanal medication against E. faecalis (11-13). The 
CHX varnishes apparently penetrate and seal tubules 
in dentin (14), reducing the level of mutans streptococci 
in exposed root surfaces (15) and it may help control 
established root caries lesions (16). However, its anti-
microbial activity against bacteria involved in root ca-
nal infections is not known. The aim of this study was 
therefore to evaluate, in vitro, the antimicrobial activi-
ty and the ability to reduce biofilm formation of three 
CHX varnishes, two of them containing thymol, against 
four E. faecalis strains and one E. durans strain.
Material and Methods
-Microorganisms and tested materials
The bacterial strains used in the study and their source 
are listed in table 1. Bacterial strains were taken from a 
4ºC stock culture and streaked out twice on BHI (Schar-
lau Chemie S.A., Barcelona, Spain) agar plates for 24 
hours at 37ºC. Colonies were suspended in BHI to ob-
tain a 1 McFarland initial bacterial suspension of ap-
proximately 3×108 colony-forming units per mL (CFU/
mL ). All strain cultures were checked for purity by 
Gram stain and colony morphology
The CHX varnishes tested were: EC40 (35% CHX, 27% 
sandarac, 38% ethanol; Biodent BV, Nijmegen, The 
Netherlands), Cervitec (CE; 1% CHX, 1% thymol, etha-
nol, ethyl acetate, polymer; Ivoclar-Vivadent, Schaan, 
Liechtenstein) and Cervitec Plus (CEP; 1% CHX, 1% 
thymol, ethanol, water, acrylate and vinylacetate-copo-
lymer; Ivoclar-Vivadent, Schaan, Liechtenstein). 
-Direct Contact Test (DCT)
The DCT used to assess the antimicrobial activity of the 
CHX varnishes is based on previously reported metho-
dology (17,18). While holding a 96-well microtiter plate 
(Nunclon Delta Surface; Nunc, Roskilde, Denmark) 
vertically, an area of established dimensions on one side 
of the wells was coated with an equal amount of each 
varnish using a cavity liner applicator. The varnishes 
were applied following the manufacturer s´ instructions, 
and were allowed to dry for 30 minutes.
A 10-μL aliquot of the initial bacterial suspension was placed 
on the surface of each varnish. Bacterial suspensions placed 
on the wall of uncoated wells served as the positive control. 
After incubation for 1 hour at 37ºC with 95% relative hu-
midity to ensure direct contact between bacteria and tested 
materials, 240 μL of sterile BHI was added to each well. 
The bacterial suspension was mixed for 1 minute, diluted 
serially and plated for viable cell counting. Ten replicates per 
strain and varnish were performed.
-Biofilm Formation Test (BFT)
The biofilm model used was the MBEC high-throughput 
(HTP) device (Innovotech, Edmonton, Alberta, Cana-
da) (3,19,20). This batch-culture apparatus has a lid with 
96 pegs that fits over a standard 96-well microtiter plate 
(21). Ten pegs were coated with each varnish, following 
the manufacturer s´ instructions; and 10 uncoated pegs 
served as the positive and sterility controls. Each assay 
was performed for a total of ten replicates per strain and 
CHX varnish in different devices.
The wells of the microtiter plate were inoculated with 150 
µL of a 1 in 30 dilution of the initial bacterial suspension, 
while 10 wells were inoculated with sterile BHI for the 
Bacteria source Species Strains
Collection E. faecalis ATCC 29212
Failed endodontic treatment E. faecalis EF-D11
Failed endodontic treatment E. durans ED-C11
Goat s´ milk cheese E. faecalis 0722
Human nosocomial infection E. faecalis U-17652
Table 1. Enterococci species and strains and their source.
1 Microbiology Laboratory, School of Dentistry, University of Granada.
2 Microbiology Laboratory, School of Science, University of Granada.
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sterility control. The coated peg lid was fitted inside the 
wells, and the device was placed on a rocking table (Swing 
Sw 8 10000-00015. OVAN, Badalona, Spain) at 5 rocks 
per minute for 24 hours of incubation at 37ºC. Biofilms 
forming on the pegs were rinsed twice with 0.9% saline 
solution for 2 minutes to remove loosely adherent plank-
tonic bacteria. The lid was then transferred to a microtiter 
recovery plate with 200 µL of BHI/well and sonicated on 
a water-table sonicator (Model 5510E–MT; Branson, Dan-
bury, CT) for 10 minutes to disrupt the biofilm structure. 
The viability of the biofilms was determined by spot plat-
ing 10-µL aliquots of recovery biofilms onto BHI agar, 
then incubating for 24 hours at 37ºC. 
The antimicrobial activity and the capacity to reduce 
biofilm formation of each CHX varnish on the strains 
tested were determined by calculating the percentage of 
reduction of viable bacteria as follows: [1-(mean CFU
CHX 
varnish
/mean CFU
initial bacterial number
)] x 100. In the DCT, the 
term ‘eradication’ was used to denote the death of 100% 
of the bacterial population. The formation of entero-
cocci biofilms was expressed as percentage of biofilm 
reduction with respect to the control. 
To compare the efficacies of the different CHX varnish-
es and the strains tested when the percentage kill varied 
EC40 Cervitec Cervitec Plus
E. faecalis ATCC 29212 98.78±0.01 36.17±0.13a,b,1 32.55±0.16a,b,1
E. faecalis EF-D1 100.00±0.00a 46.86±0.22a,1 42.85±0.11a,1
E. faecalis 072 100.00±0.00a 77.59±0.03 83.08±0.05
E. faecalis U-1765 100.00±0.00a 37.22±0.09b 18.51±0.18b
E. durans ED-C1 100.00±0.00a 88.46±0.06 99.95±0.00
from 100%, the Student t-test was used, previously sub-
jecting data to the Anscombe transformation.
Results
The results of the antibacterial effects of the CHX 
varnishes from the DCT are listed in table 2. EC40 
showed the best antibacterial action, eradicating all the 
enterococci strains except for E. faecalis ATCC 29212 
(98.78%). CE and CEP, while variable in effectivity, 
produced the greatest kill percentages of strains E. fae-
calis 072 and E. durans ED-C1. 
No significant differences were obtained when the ef-
fects of CE were compared with those of CEP against 
E. faecalis ATCC 29212 (p=0.549) or E. faecalis EF-D1 
(p=0.705); but differences were indeed significant for 
the rest of the bacteria tested. 
Table 3 shows the percentage of reduction of biofilm 
formation. E. faecalis 072 formed no biofilm on any of 
the three varnishes tested (100% reduction); E. faeca-
lis ATCC 29212 and E. durans ED-C1 were likewise 
unable to create biofilm upon EC40. The percentage of 
biofilm reduction on CE and CEP was over 92% in all 
cases except for E. faecalis U-1765 on CEP, which gave 
a mean value of 76.42%.
EC40 Cervitec Cervitec Plus
E. faecalis ATCC 29212 100.00±0.00a 95.57±0.05a,1 98.71±0.01a,1
E. faecalis EF-D1 99.98±0.00b,1 98.70±0.01b,1 92.55±0.04
E. faecalis 072 100.00±0.00a,1 100.00±0.001 100.00±0.001
E. faecalis U-1765 99.03±0.01b,1 98.39±0.03b,1 76.42±0.22
E. durans ED-C1 100.00±0.00a 92.69±0.04a 96.69±0.05a
Table 2. Percentage of kill of five enterococci strains after direct contact with chlorhexi-
dine varnishes (mean±SD).
Read vertically, same letters indicate non-significant differences.
Read horizontally, same numbers indicate non-significant differences.
Table 3. Percentage of reduction of biofilm formation of four E. faecalis strains and one E. 
durans strain by chlorhexidine varnishes (mean±SD).
Read vertically, same letters indicate non-significant differences.
Read horizontally, same numbers indicate non-significant differences.
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Discussion
The use of intracanal medication can help eliminate 
the bacteria remaining after chemo-mechanical instru-
mentation and may prevent microorganism invasion 
between treatment appointments (1). Our results sug-
gest that all three varnishes studied exert antimicrobial 
activity against the five strains tested, and are capable 
of preventing or reducing the formation of biofilm.
Although the most frequently used intracanal medica-
ment is calcium hydroxide, when CHX is used, E. fae-
calis is better eliminated from dentinal tubules (5). As 
inter-appointment medication, it may be applied in the 
form of a gel (8) or incorporated into sustained-release 
devices (13). The potential benefits of CHX varnishes 
in endodontics may stem from a greater and more pro-
longed release from dental tissue than with CHX gels 
(22), and their ability to penetrate and disinfect dentin 
tubules of the surface root (14). 
The bacteria selected for our study were enterococci 
strains, particularly E. faecalis, which are often isolated 
from necrotic or improperly filled root canal systems (23). 
E. faecalis ATCC 29212 is a strain of reference widely 
used in antimicrobial susceptibility studies (13). Moreo-
ver, two enterococci strains isolated from failed endo-
dontic treatments were studied, E. faecalis EF-D1 and E. 
durans ED-C1, the latter reportedly present in root canals 
(24). The origin of enterococci found in the oral cavity 
is unclear; and whereas the most likely source would be 
food (25), nosocomial infections are another possibility. 
We therefore used strains pertaining to both sources: E. 
faecalis 072 (26) and E. faecalis U-1765.
A DCT (17) with several modifications was used to eva-
luate the antimicrobial activity of the varnishes, since it 
permits a direct evaluation of their bactericidal effects. 
This method is quantitative and reliable, and reproduces 
the contact of the test microorganism with the varnish-
es. Our results showed that EC40 was the most effective 
CHX varnish, eradicating all the strains tested, except 
E. faecalis ATCC 29212. CE and CEP gave the highest 
kill percentages in contact with E. durans ED-C1 (over 
88%) and E. faecalis 072 (over 77%), CEP proving to 
be significantly more effective than CE. Neither varnish 
produced kill over 50% against the rest of the strains. 
This may be due to the lesser concentration of the active 
ingredients in these preparations, and to the presence 
of polymers or copolymers in their formulation, which 
may limit their diffusion.
For the BFT, the MBEC-HTP device was considered ap-
propriate because it allows for the simultaneous forma-
tion of 96 statistically equivalent biofilms under similar 
conditions (19, 21). After 24 hours of incubation (3), the 
results of the positive controls showed each strain to have 
a different capacity for forming biofilm. E. faecalis 072 
created a lesser amount of biofilm, which would explain 
its 100% reduction with the three varnishes. The two 
strains isolated from root canals, E. durans ED-C1 fol-
lowed by E. faecalis EF-D1, formed a great amount of 
biofilm. This finding contrasts with the results reported 
by Duggan and Sedgley (27), who showed E. faecalis 
strains from endodontic sources to have a lower inherent 
capacity for biofilm formation. 
In parallel to the results seen for DCT, EC40 was the 
most effective varnish, able to fully inhibit biofilm 
formation of three strains. This may be attributed to 
its high concentration of CHX, which would provide 
greater substantive antimicrobial activity (28). Lee et 
al (13) similarly obtained strong antimicrobial action 
on contaminated dentin blocks with E. faecalis using a 
polymeric CHX controlled device with 40% CHX. CE 
and CEP exhibited a lesser capacity to inhibit biofilm 
formation in our study, which also varied depending on 
the species involved. The lower concentration of CHX 
(1%), even though it included thymol in its composition 
(29), might explain these results. However, both these 
varnishes achieved a percentage of reduction over 92%; 
in contrast, CEP was not very effective against E. faeca-
lis U-1765 (76.42%). There is no clear evidence pointing 
to one of these substances as better than the other, a 
point brought out previously in the context of cariogenic 
bacteria (30).
The study described here demonstrates that the CHX 
varnishes —and particularly EC40— exert effective 
antimicrobial action against the enterococci strains test-
ed, and that they are able to inhibit or considerably re-
duce the formation of biofilms of these bacteria. Despite 
the limitations of this in vitro study, we may state that 
the results are promising, and encourage further stud-
ies to evaluate other properties of varnishes and new 
sustained-release systems. 
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